IDENIX PHARM (NASDAQ:IDIX)
3.00
+0.05 (1.69%)
| IDENIX PHARM (NASDAQ:IDIX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.95 | 52 Week High | $6.21 | ||
| Open | $3.00 | 52 Week Low | $1.81 | ||
| Day High | $3.00 | P/E | N/A | ||
| Day Low | $2.93 | EPS | $-0.93 | ||
| Volume | 80,642 | ||||
| More IDIX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| TSRA | 3 | GNW | 3 |
| BARE | 3 | NANO | 3 |
| CEC | 3 | JDAS | 3 |
| AXTI | 3 | GFIG | 3 |
| LVS | 3 | NVTL | 3 |
| SXE | 3 | RRR | 2 |
Entities who have mentioned IDIX
- Deutsche Bank | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- After-Hours Movers | View Related Stories »
- UBS | View Related Stories »
- Bankruptcy | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- Chrysler LLC | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- ThinkPanmure | View Related Stories »
- Goldman Sachs | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- ThinkEquity | View Related Stories »
- JMP Securities | View Related Stories »
- Morgan Stanley | View Related Stories »
- Standard & Poor's | View Related Stories »
- Dividend | View Related Stories »
- Crude Oil | View Related Stories »
View All Major News StreetInsider.com Major News for IDIX
- Idenix Pharmaceuticals (IDIX) Tops Q3 EPS by 6c; Retains Worldwide Rights to Develop and Commercialize IDX184
- Idenix Pharmaceuticals (IDIX) Misses Q2 View By 3c
- Idenix Pharma (IDIX) Reports Better-Than Expected Q4 Loss of $0.25
View All ReportsStreetInsider.com Reports on IDIX
- Morning Movers 01/11: PEIX, EPCT, MMR, TUES, KTII Higher; CYCC, LUNA, IOC, ASBC, HOGS Lower
- Idenix Pharma (IDIX) Announces Progress in Three HCV Programs; Updates on FY09 Guidance
- Caris & Co Downgrades Idenix Pharmaceuticals (IDIX) to Above Average
- Morning Movers 10/30: PVFC, WPTE, CNXT, HPOL, TVL, MSTR Higher; NVTL, GFIG, TSRA, GGC, IDIX Lower
- Idenix (IDIX) Announces Presentations of IDx184 at AASLD in Boston
View All Press ReleasesCompany Press Releases on IDIX
- Idenix Pharmaceuticals To Present at 12th Annual BIO CEO & Investor Conference
- Idenix Pharmaceuticals Highlights Progress in Three HCV Programs
- Idenix Pharmaceuticals to Present at the 28th Annual J. P. Morgan Healthcare Conference
StreetInsider Reports on IDIX by Category
View All BlogsBlogs on IDIX
- The Future of Biotech: Party Like It's 1999
- Biotech Discounts Galore
- Analyst upgrades, downgrades and initiations: CIEN, DLTR, EXPE, IBM, ZION ...
- Analyst upgrades, downgrades and initiations: CLX, ED, JBHT, HMC, PCG ...
- Ugly Stock Stats from an Ugly Bear
View All FilingsSEC Filings on IDIX
- Form 8-K IDENIX PHARMACEUTICALS For: Jan 11
- Form 4 IDENIX PHARMACEUTICALS For: Dec 15 Filed by: HODGSON THOMAS R
- Form 4 IDENIX PHARMACEUTICALS For: Dec 10 Filed by: HODGSON THOMAS R
Comments on IDIX
No comments are currently available.
